This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Bacterial Infections  • Alert me on articles by topic

JAMA. 2006;295:488-490.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

MMWR. 2005;54:1283-1286

3 figures omitted

Pertussis is a highly contagious, vaccine-preventable bacterial illness characterized by paroxysmal cough, posttussive vomiting, and inspiratory whoop. Pertussis also can occur as a mild or moderate cough illness in persons who are partially immune.¹ In the United States, most hospitalizations and nearly all deaths from pertussis are reported in infants aged <6 months, but substantial morbidity does occur in other age groups. Infant/childhood vaccination has contributed to a reduction of more than 90% in pertussis-related morbidity and mortality since the early 1940s in the United States.¹ Estimates of childhood vaccination coverage with 3 doses of pertussis-containing vaccine have exceeded 90% since 1994; however, reported pertussis cases increased from a historic low of 1,010 in 1976 to 11,647 cases in 2003.² A substantial increase in reported cases has occurred among adolescents, who become susceptible to pertussis approximately 6-10 years after childhood vaccination.^3-4 Recently, booster vaccines for . . . [Full Text of this Article]

Reported by:

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Incorporating Vaccine-Preventable Disease Surveillance Into the National Health Information Network: Leveraging Children's Hospitals
Fine et al.
Pediatrics 2006;118:1431-1438.
ABSTRACT | FULL TEXT